SCHEMBL25821506

SCHEMBL25821506

CCCCCOc1cc(C(=O)Oc2ccc3ccccc3c2-c2c(OC(=O)c3ccc(/N=N/c4ccccc4)cc3)ccc3ccccc23)cc(C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.40
▸ CNR1 P21554 3/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ PLA2G2A P14555 1/20 0.40
▸ THRA P10827 2/20 0.39
▸ THRB P10828 2/20 0.39
▸ PPARG P37231 1/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ ACR P10323 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25821511 1.00 CNR2 (0.40) CNR2CNR1CYP2C9PLA2G2ATHRA
SCHEMBL25821514 0.99 PLA2G2A (0.41) CNR2CNR1CYP2C9PLA2G2ATHRA
SCHEMBL25821526 0.99 PLA2G2A (0.41) CNR2CNR1CYP2C9PLA2G2ATHRA
SCHEMBL25821501 0.87 MAPT (0.48) PPARGPPARDPPARAL3MBTL1TDP1
SCHEMBL25821518 0.82 PRSS1 (0.42) CNR2CNR1THRATHRBL3MBTL1
SCHEMBL31404682 0.82 RARB (0.49) CNR2CNR1CYP2C9PRSS1ACR
SCHEMBL31404692 0.79 RARB (0.46) CNR2CNR1CYP2C9PRSS1ACR
SCHEMBL31404691 0.78 RARB (0.47) CNR2CNR1CYP2C9PRSS1ACR
SCHEMBL31404687 0.77 RARB (0.46) CNR2THRBPRSS1ACRMAPT
SCHEMBL31404689 0.77 RARB (0.44) CNR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230221596-A1 GREEN LIGHT SACRIFICIAL LAYER AND METHOD OF MANUFACTURING TOUCH DISPLAY DEVICE TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230221596-A1 GREEN LIGHT SACRIFICIAL LAYER AND METHOD OF MANUFACTURING TOUCH DISPLAY DEVICE TTL, CUL4B, CUL5 CNR2 3817/4885CNR1 4373/4885CYP2C9 1864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback